Value of carcinoembryonic antigen and cytokeratins for the detection of recurrent disease following curative resection of colorectal cancer

World Journal of Gastroenterology

Volumn 12, Issue 24, 2006, Pages 3891-3894

  Fernandes, Luís César ^a   Kim, Su B ^a   Saad, Sarhan S ^a   Matos, Delcio ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Carcinoembryonic antigen; Colorectal neoplasms; Cytokeratin; Residual neoplasm

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN; TISSUE POLYPEPTIDE ANTIGEN;

ACCURACY; ADULT; AGED; ARTICLE; BRAZIL; CANCER RECURRENCE; COLON RESECTION; COLONOSCOPY; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PROTEIN BLOOD LEVEL; RECTUM RESECTION; RECURRENCE RISK; REOPERATION; STATISTICAL SIGNIFICANCE;

EID: 33745854265     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i24.3891     Document Type: Article

References (29)

1. Bates SE. Clinical applications of serum tumor markers. Ann Intern Med 1991; 115: 623-638
2. Gold P, Freedman SO. Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J Exp Med 1965; 121: 439-462
3. Hunerbein M. The value of tumor markers in colorectal cancer. Recent Results Cancer Res 1998; 146: 48-55
4. Carriquiry LA, Pineyro A. Should carcinoembryonic antigen be used in the management of patients with colorectal cancer? Dis Colon Rectum 1999; 42: 921-929
5. Fisher ER, Sass R, Palekar A, Fisher B, Wolmark N. Dukes classification revisited. Findings from the National Surgical Adjuvant Breast and Bowel Projects (Protocol R-01). Cancer 1989; 64: 2354-2360
6. Wiratkapun S, Kraemer M, Seow-Choen F, Ho YH, Eu KW. High preoperative serum carcinoembryonic antigen predicts metastatic recurrence in potentially curative colonic cancer: results of a five-year study. Dis Colon Rectum 2001; 44: 231-235
7. Lucha PA Jr, Rosen L, Olenwine JA, Reed JF 3rd, Riether RD, Stasik JJ Jr, Khubchandani IT. Value of carcinoembryonic antigen monitoring in curative surgery for recurrent colorectal carcinoma. Dis Colon Rectum 1997; 40: 145-149
8. Fuszek P, Lakatos P, Tabak A, Papp J, Nagy Z, Takacs I, Horvath HC, Lakatos PL, Speer G. Relationship between serum calcium and CA 19-9 levels in colorectal cancer. World J Gastroenterol 2004; 10: 1890-1892
9. Kim SB, Fernandes LC, Saad SS, Matos D. Assessment of the value of preoperative serum levels of CA 242 and CEA in the staging and postoperative survival of colorectal adenocarcinoma patients. Int J Biol Markers 2003; 18: 182-187
10. Fernandez-Fernandez L, Tejero E, Tieso A. Significance of CA 72-4 in colorectal carcinoma. Comparison with CEA and CA 19-9. Eur J Surg Oncol 1995; 21: 388-390
11. Bjorklund B, Bjorklund V. Specificity and basis of the tissue polypeptide antigen. Cancer Detect Prev 1983; 6: 41-50
12. Ishigami SI, Arii S, Furutani M, Niwano M, Harada T, Mizumoto M, Mori A, Onodera H, Imamura M. Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer. Br J Cancer 1998; 78: 1379-1384
13. Polge A, Bourgaux JF, Bancel E, Pignodel C, Boyer JC, Poirey S, de Bornier BM, Balmes JL, Bali JP. p53 and follow-up of colorectal adenocarcinomas. Dig Dis Sci 1998; 43: 1434-1442
14. Carpelan-Holmstrom M, Haglund C, Lundin J, Alfthan H, Stenman UH, Roberts PJ. Independent prognostic value of preoperative serum markers CA 242, specific tissue polypeptide antigen and human chorionic gonadotrophin beta, but not of carcinoembryonic antigen or tissue polypeptide antigen in colorectal cancer. Br J Cancer 1996; 74: 925-929
15. Correale M, Arnberg H, Blockx P, Bombardieri E, Castelli M, Encabo G, Gion M, Klapdor R, Martin M, Nilsson S. Clinical profile of a new monoclonal antibody-based immunoassay for tissue polypeptide antigen. Int J Biol Markers 1994; 9: 231-238
16. Plebani M, De Paoli M, Basso D, Roveroni G, Giacomini A, Galeotti F, Corsini A. Serum tumor markers in colorectal cancer staging, grading, and follow-up. J Surg Oncol 1996; 62: 239-244
17. Lewenhaupt A, Ekman P, Eneroth P, Nilsson B, Nordstrom L. Tissue polypeptide antigen (TPA) as a prognostic aid in human prostatic carcinoma. Prostate 1985; 6: 285-291
18. Panza N, Pacilio G, Campanella L, Peluso G, Battista C, Amoriello A, Utech W, Vacca C, Lombardi G. Cancer antigen 125, tissue polypeptide antigen, carcinoembryonic antigen, and beta-chain human chorionic gonadotropin as serum markers of epithelial ovarian carcinoma. Cancer 1988; 61: 76-83
19. Gronowitz JS, Bergstrom R, Nou E, Pahlman S, Brodin O, Nilsson S, Kallander CF. Clinical and serologic markers of stage and prognosis in small cell lung cancer. A multivariate analysis. Cancer 1990; 66: 722-732
20. Tizzani A, Casetta G, Cavallini A, Piana P, Piantino P. Blood and urine determinations of tissue polypeptide antigen in patients with bladder carcinoma. Minerva Urol Nefrol 1990; 42: 69-71
21. Barak M, Steiner M, Finkel B, Abrahamson J, Antal S, Gruener N. CA-15.3, TPA and MCA as markers for breast cancer. Eur J Cancer 1990; 26: 577-580
22. Fletcher RH, Fletcher SW, Wagner EW. Epidemiologia Clínica. Porto Alegre: Artes Médicas, 1989
23. Neter J, Kutner MH, Nachtsheim CJ, Wasserman W. Applied Linear Statistical Models. 4th ed. Chicago: Irwin, 1996
24. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Tangen C. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA 1993; 270: 943-947
25. Bast RC Jr, Ravdin P, Hayes DF, Bates S, Fritsche H Jr, Jessup JM, Kemeny N, Locker GY, Mennel RG, Somerfield MR. 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001; 19: 1865-1878
26. Minton JP, Hoehn JL, Gerber DM, Horsley JS, Connolly DP, Salwan F, Fletcher WS, Cruz AB Jr, Gatchell FG, Oviedo M. Results of a 400-patient carcinoembryonic antigen second-look colorectal cancer study. Cancer 1985; 55: 1284-1290
27. Ohlsson B, Breland U, Ekberg H, Graffner H, Tranberg KG. Follow-up after curative surgery for colorectal carcinoma. Randomized comparison with no follow-up. Dis Colon Rectum 1995; 38: 619-626
28. Secco GB, Fardelli R, Rovida S, Gianquinto D, Baldi E, Bonfante P, Derchi L, Ferraris R. Is intensive follow-up really able to improve prognosis of patients with local recurrence after curative surgery for rectal cancer? Ann Surg Oncol 2000; 7: 32-37
29. Fernandes LC, Kim SB, Matos D. Cytokeratins and carcinoembryonic antigen in diagnosis, staging and prognosis of colorectal adenocarcinoma. World J Gastroenterol 2005; 11: 645-648